£325.00

It has never been this cheap. We have no record of a lower price.

£325 today · cheaper than every other day in the last 3 months

Pancreatic Cancer Drug Outlook: Africa & Middle East Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days · 88 data points

Historical
Generating forecast…
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 12 August 2026 02 September 2026 24 September 2026 16 October 2026 07 November 2026
View at Amazon ↗

Price data checked 3 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 88 days • 1 price levels

Days at Price
88 days 0 22 44 66 88 £325 Days at Price

Price Analysis

Most common price: £325 (88 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 88 days

Description

This econometric study provides a detailed outlook for pancreatic cancer drugs across Africa and the Middle East for the 2013-2018 period. By utilizing econometric models that project fundamental economic dynamics, the report generates latent demand estimates for each country. Readers gain access to potential industry earnings (P.I.E.) expressed in millions of U.S. dollars for every year reported. The study includes comparative benchmarks, such as the percent share each country holds within its specific region and of the global market. These metrics allow for quick assessments of individual countries compared to others in the sector. This resource is designed for professionals requiring data-driven insights into regional pharmaceutical market potential and economic projections.

Key Features

Provides econometric projections for pancreatic cancer drug demand in Africa and the Middle East from 2013 to 2018.

Includes potential industry earnings (P.I.E.) for each reported year in millions of U.S. dollars.

Offers comparative benchmarks by calculating the percent share of each country relative to its region and the globe.

Uses econometric models to project fundamental economic dynamics across individual countries and entire regions.

Delivers latent demand estimates to help gauge country-specific market potential via comparative data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

Pancreatic Cancer Drug Outlook in Latin America 2013-2018
99% match

Pancreatic Cancer Drug Outlook in Latin America 2013-2018

£325.00 26 Aug 2026
Pancreatic Cancer Drug Outlook in Europe 2013-2018 Study
99% match

Pancreatic Cancer Drug Outlook in Europe 2013-2018 Study

£325.00 07 Nov 2026
Pancreatic Cancer Drug Outlook 2013-2018 - North America
99% match

Pancreatic Cancer Drug Outlook 2013-2018 - North America

£325.00 25 Aug 2026
The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East
99% match

The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East

£325.00 26 Aug 2026
Pancreatic Cancer Drug Outlook in Africa 2011-2016 Study
99% match

Pancreatic Cancer Drug Outlook in Africa 2011-2016 Study

£325.00 26 Aug 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
99% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana

£325.00 25 Aug 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
98% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 08 Nov 2026
The 2021-2026 World Outlook for Pancreatic Cancer Drugs
98% match

The 2021-2026 World Outlook for Pancreatic Cancer Drugs

£795.00 04 Nov 2026
Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028
97% match

Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028

£520.00 29 Aug 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China

£495.00 02 Sep 2026
Exocrine Pancreatic Insufficiency Therapeutics India Outlook
97% match

Exocrine Pancreatic Insufficiency Therapeutics India Outlook

£515.00 28 Oct 2026
Pancreatic Cancer: Insights into Molecular Mechanisms and Novel Approaches to Early Detection and Treatment
97% match

Pancreatic Cancer: Insights into Molecular Mechanisms and Novel Approaches to Early Detection and Treatment

Price unavailable
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
97% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 26 Sep 2026
Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028
97% match

Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028

£490.00 28 Oct 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan

£495.00 31 Oct 2026
Understanding Pancreatic Cancer: Global Strategies and African Perspectives
97% match

Understanding Pancreatic Cancer: Global Strategies and African Perspectives

CRC Press

£80.59 22 Sep 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
96% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 28 Oct 2026
Pancreatic Cancer: Basic Mechanisms and Therapies (Volume 159) (Advances in Cancer Research, Volume 159)
96% match

Pancreatic Cancer: Basic Mechanisms and Therapies (Volume 159) (Advances in Cancer Research, Volume 159)

Elsevier

£117.99 10 Sep 2026
Pancreatic Cancer: Current Therapeutics and Future Directions
96% match

Pancreatic Cancer: Current Therapeutics and Future Directions

Springer

£88.21 24 Sep 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
96% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
IntechOpen Pancreatic Cancer - Clinical Management Book
96% match

IntechOpen Pancreatic Cancer - Clinical Management Book

IntechOpen

£139.00 13 Oct 2026
Current and Emerging Therapies in Pancreatic Cancer
96% match

Current and Emerging Therapies in Pancreatic Cancer

Springer

£89.30 30 Sep 2026
Pancreatic Cancer: A Multidisciplinary Approach
96% match

Pancreatic Cancer: A Multidisciplinary Approach

Springer

£156.60 02 Oct 2026
Pancreatic Cancer: A Multidisciplinary Approach - Springer
96% match

Pancreatic Cancer: A Multidisciplinary Approach - Springer

Springer

£111.89 02 Oct 2026